Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: A 12-year follow-up study

BJU International

Volumn 110, Issue 5, 2012, Pages 668-673

  Tseng, Chin Hsiao ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

insulin; mortality; prostate cancer; Taiwan; type 2 diabetes mellitus

Indexed keywords

INSULIN;

ADULT; AGE; ARTICLE; BODY MASS; CANCER MORTALITY; COHORT ANALYSIS; DIABETIC PATIENT; DISEASE DURATION; DRUG USE; ETHNICITY; FOLLOW UP; GEOGRAPHY; GLYCEMIC CONTROL; HAZARD RATIO; HUMAN; HYPERGLYCEMIA; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK FACTOR; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; TAIWAN;

EID: 84865347945     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10924.x     Document Type: Article

References (33)

1. Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care 2010; 33: 1674-85
2. Bonovas S, Filioussi K, Tsantes A,. Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia 2004; 47: 1071-8 (Pubitemid 38918167)
3. Kasper JS, Giovannucci E,. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2056-62 (Pubitemid 44877026)
4. Li Q, Kuriyama S, Kakizaki M, et al. History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study. Cancer Causes Control 2010; 21: 1025-32
5. Waters KM, Henderson BE, Stram DO, Wan P, Kolonel LN, Haiman CA,. Association of diabetes with prostate cancer risk in the multiethnic cohort. Am J Epidemiol 2009; 169: 937-45
6. Tseng CH,. Prostate cancer mortality in Taiwanese men: increasing age-standardized trend in general population and increased risk in diabetic men. Ann Med 2011; 43: 142-50
7. Tseng CH,. Diabetes and risk of prostate cancer: a study using the National Health Insurance. Diabetes Care 2011; 34: 616-21
8. Nandeesha H,. Insulin: a novel agent in the pathogenesis of prostate cancer. Int Urol Nephrol 2009; 41: 267-72
9. Hsing AW, Chua S Jr, Gao YT, et al. Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 2001; 93: 783-9 (Pubitemid 32514802)
10. Tseng CH, Tseng CP, Chong CK, et al. Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 2006; 49: 1755-60
11. Tseng CH,. Mortality and causes of death in a national sample of diabetic patients in Taiwan. Diabetes Care 2004; 27: 1605-9
12. Hammarsten J, Damber JE, Peeker R, Mellström D, Högstedt B,. A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer. Cancer Epidemiol 2010; 34: 574-9
13. Hubbard JS, Rohrmann S, Landis PK, et al. Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging. Urology 2004; 63: 253-8 (Pubitemid 38234413)
14. Stattin P, Söderberg S, Hallmans G, et al. Leptin is associated with increased prostate cancer risk: a nested case-referent study. J Clin Endocrinol Metab 2001; 86: 1341-5 (Pubitemid 32323026)
15. Nimptsch K, Kenfield S, Jensen MK, et al. Dietary glycemic index, glycemic load, insulin index, fiber and whole-grain intake in relation to risk of prostate cancer. Cancer Causes Control 2011; 22: 51-61
16. Lai GY, Helzlsouer KJ, Clipp SL, Rifai N, Platz EA,. Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study. Cancer Prev Res (Phila) 2010; 3: 1334-41
17. Roddam AW, Allen NE, Appleby P, et al. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 2008; 149: 461-71
18. Mikami K, Ozasa K, Nakao M, et al. JACC Study Group. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a nested case control study in large scale cohort study in Japan. Asian Pac J Cancer Prev 2009; 10 (Suppl.): 57-61
19. He XX, Tu SM, Lee MH, Yeung SC,. Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients. Ann Oncol 2011; 22: 2640-5
20. Shabsigh R, Crawford ED, Nehra A, Slawin KM,. Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review. Int J Impot Res 2009; 21: 9-23
21. Morgentaler A, Traish AM,. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol 2009; 55: 310-20
22. Rhoden EL, Morgentaler A,. Symptomatic response rates to testosterone therapy and the likelihood of completing 12 months of therapy in clinical practice. J Sex Med 2010; 7: 277-83
23. Huggins C, Hodges CV,. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941; 1: 293-7
24. Huggins C, Stevens RE Jr, Hodges CV,. Studies on prostatic cancer. II. The effects of castration on advanced carcinoma of the prostate gland. Arch Surg 1941; 43: 209-23
25. Jones TH,. Effects of testosterone on type 2 diabetes and components of the metabolic syndrome. J Diabetes 2010; 2: 146-56
26. Kashyap SR, Defronzo RA,. The insulin resistance syndrome: physiological considerations. Diab Vasc Dis Res 2007; 4: 13-9 (Pubitemid 46649069)
27. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R,. Diabetes and cancer. Endocr Relat Cancer 2009; 16: 1103-23
28. Wigle DT, Turner MC, Gomes J, Parent ME,. Role of hormonal and other factors in human prostate cancer. J Toxicol Environ Health B Crit Rev 2008; 11: 242-59 (Pubitemid 351451260)
29. Hickey K, Do KA, Green A,. Smoking and prostate cancer. Epidemiol Rev 2001; 23: 115-25 (Pubitemid 32906623)
30. Batty GD, Kivimaki M, Gray L, Smith GD, Marmot MG, Shipley MJ,. Cigarette smoking and site-specific cancer mortality: testing uncertain associations using extended follow-up of the original Whitehall study. Ann Oncol 2008; 19: 996-1002 (Pubitemid 351627320)
31. Ilić M, Vlajinac H, Marinković J,. Case-control study of risk factors for prostate cancer. Br J Cancer 1996; 74: 1682-6 (Pubitemid 26386103)
32. Batty GD, Kivimäki M, Clarke R, Davey Smith G, Shipley MJ,. Modifiable risk factors for prostate cancer mortality in London: forty years of follow-up in the Whitehall study. Cancer Causes Control 2011; 22: 311-8
33. Trummer H, Habermann H, Haas J, Pummer K,. The impact of cigarette smoking on human semen parameters and hormones. Hum Reprod 2002; 17: 1554-9 (Pubitemid 34661807)